Journal: PLoS ONE
Article Title: CSNK1G2 differently sensitizes tamoxifen-induced decrease in PI3K/AKT/mTOR/S6K and ERK signaling according to the estrogen receptor existence in breast cancer cells
doi: 10.1371/journal.pone.0246264
Figure Lengend Snippet: (A) Immunoblots for ER, PR, and HER2 in different human breast cancer cell lines. ER + (MCF-7 and T-47D) and ER - (MDA-MB-231) breast cancer cell lines were prepared for western blotting. The expression pattern of different hormone receptors was determined. Protein expression levels were compared to expression levels of α-tubulin; each value under the blots indicates relative protein expression levels determined by densitometric analysis, unless specifically mentioned (mean (SD); n = 4). Dots denote ER + (MCF-7 and T-47D) or ER - (MDA-MB-231) breast cancer cells treated with different concentrations of (B) TAM and (C) β-estradiol (E 2 ). Bars denote (D) ER + MCF-7, (E) ER + T-47D, and (F) ER - MDA-MB-231 breast cancer cells treated with TAM after silencing with NC or CNSK1G2 siRNA. (G) ER - MDA-MB-231 also transiently transfected with GFP-C1 or GFP-ERα plasmid DNA as well as with NC or CSNK1G1 siRNA. Twenty-four hours after transfection, cells were treated with vehicle or 1 μM TAM for 24 h. Cellular toxicity was then measured using the MTT assay (mean (SD); n = 4; * P < 0.05, ** P < 0.01, # P < 0.001 vs . each represented counterpart).
Article Snippet: pGFP-C1-ERα (GFP-ERα), a mammalian expression of ERα fused to GFP, was purchased from Addgene (#28230; Watertown, MA, USA).
Techniques: Western Blot, Expressing, Transfection, Plasmid Preparation, MTT Assay